Carisma Therapeutics Joins Oppenheimer 35th Annual Healthcare Life Sciences Conference
Carisma Therapeutics CEO to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences conference Philadelphia, PA – February 5, 2025 – Carisma Therapeutics Inc. (Nasdaq: CARM), a trailblazer in macrophage-focused therapeutics, announced today that Steven Kelly, President and Chief Executive Officer, will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference. The event … Read more